Erasca Foundation proposes $117K Erasca share sale
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Erasca, Inc. (ERAS) reports that Erasca Foundation proposed to sell 8,333 common shares, with an aggregate market value of $117,476.95 and an approximate sale date of June 15, 2026. Merrill Lynch is listed as the broker. The notice gives January 10, 2024 as the date of adoption of the Rule 10b5-1 plan.
The Foundation reported selling 8,333 shares on March 16, April 15 and May 15, 2026. Gross proceeds for those sales were $116,855.46, $150,843.19 and $84,528.29, respectively. David Chacko signed the notice.
Key Figures
Key Terms
Rule 10b5-1 regulatory
Aggregate Market Value financial
Gross Proceeds financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
AI-generated analysis. How Rhea-AI works. Not financial advice.